Diabetes Inhibits Gr-1+ Myeloid Cell Maturation via Cebpa Deregulation. (2015)
Attributed to:
Regenerative medicine: instrumentation for flow cytometry and cell printing
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.2337/db14-1895
PubMed Identifier: 26324181
Publication URI: http://europepmc.org/abstract/MED/26324181
Type: Journal Article/Review
Volume: 64
Parent Publication: Diabetes
Issue: 12
ISSN: 0012-1797